ArticleJournal for immunotherapy of cancer2024

Targeting epigenetic regulation and post-translational modification with 5-Aza-2' deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy.

Jessie S Kroonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.